While this manuscript was in preparation, two studies reported the regulation of serine/one-carbon metabolic pathways by IGF2BP3 in hepatocellular carcinoma.56,57 These studies identified different targets of IGF2BP3, which may reflect cell-type- or other context-dependent regulation. This evidence concerns the gene IGF2BP3 and hepatocellular carcinoma.